This is a discussion on Hollis-Eden touts new diabetes data; Nastech announces positive insulin report within the Biotechnology News forum, part of the Industry News and Updates category; > Hollis-Eden says new data from a Phase I/II trial of triolex for type 2 diabetes continues to ...
|
|||||||
| Register | Help | Members List | Mark Forums Read |
|
|||
|
> Hollis-Eden says new data from a Phase I/II trial of triolex for type 2 diabetes continues to show the drug is safe and well tolerated while also demonstrating that it significantly improves Read more...
More... |
![]() |
| Thread Tools | |
| Display Modes | |
|
|
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| United posts positive data for inhaled PAH drug | industry_news | Biotechnology News | 0 | 05-23-2008 04:06 PM |
| Renovo reports positive Juvista data | industry_news | Biotechnology News | 0 | 04-22-2008 03:11 PM |
| SPOTLIGHT: Novartis touts new MS data | industry_news | Biotechnology News | 0 | 04-16-2008 02:19 PM |
| Introgen gets positive Phase III Advexin data | industry_news | Biotechnology News | 0 | 04-15-2008 02:27 PM |
| Phase III data sinks Keryx's diabetes drug | industry_news | Biotechnology News | 0 | 03-11-2008 02:26 PM |